113 results on '"Matsuura E"'
Search Results
2. Inflammasomes and Inflammatory Cytokines in Early Atherosclerosis
3. THU0181 SOLUBLE VASCULAR BIOMARKERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: EFFECTS OF ONE-YEAR ANTI-TNF-Α THERAPY
4. Immunology of anti-phospholipid antibodies and cofactors
5. A clinical trial evaluating the safety and efficacy of oral L-arginine therapy in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
6. Sequence analysis identified an HTLV-1 subtype and mutations of host restriction factors susceptible to HAM/TSP
7. The estimated number of HTLV-1 carriers in Kagoshima
8. Clinical and electrophysiological characteristics of 71 patients with charcot-marie-tooth disease caused by MPZ mutation
9. 31 Harnessing autoimmunity (disease-specific autoantibody and its variant) in theranostics of disease
10. A proposal: Isaacs’ syndrome (acquired neuromyotonia) diagnostic criteria
11. HTLV-1 complete genome analysis identified a risk subtype for HTLV-1-associated myelopathy/tropical spastic paraparesis and subtype-specific amino acid changes
12. Rapid reduction in iFLC predicts achievement of VGPR after 4 cycles of VCD treatment: Shimousa MM-01 VCD study
13. AB0082 Effects of Anti-Tnf Therapy on Circulating Oxldl-Beta2Gpi Complex Levels in Arthritis
14. A6.13 Effects of anti-tnf therapy on circulating oxLDL-BETA2GPI complex levels in arthritis
15. Urbach Tail and Phase Transition of Ferroelectric Semiconductor SbSBr
16. Conductivity and Hall Effect at High Magnetic Fields in Sb-Doped Si near the Metal-Nonmetal Transition
17. Spin-Lattice Relaxation at High Temperatures in Heavily Doped n-Type Silicon
18. Spin-Lattice Relaxation at High Temperatures in Heavily Doped n-Type Silicon
19. Significant accumulation of oxLDL/beta2-glycoprotein i complexes in arterial lesions of whhl rabbits: PET/CT imaging using an auto antibody's scFv variant
20. Circulating pro-atherogenic oxidized-LDL/β2-glycoprotein I complexes are detected in arterial and venous diseases and are independent predictors of carotid arterial disease
21. Two cases of POEMS syndrome: Initially misdiagnosed as CIDP
22. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4gene expression in combination with ETS family proteins
23. Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation
24. Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus
25. On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes
26. 239 ANTI-ATHEROGENIC EFFECTS OF PERSIMMON (DIOSPYROS KAKI) PEEL IN LDLR−/−-DEFICIENT MICE: PLAQUE REDUCTION, INHIBITION OF OXLDL/β2GPI AUTOANTIGEN AND THROMBOXANE PLATELET ACTIVATION
27. 400 ATHEROGENIC IN VIVO LDL OXIDATION, THROMBOXANE-MEDIATED PLATELET ACTIVATION AND SIMULTANEOUS OCCURRENCE OF NATURAL IMMUNITY IN ATHEROSCLEROSIS-PRONE (LDLR−/− AND APOE−/−) MICE
28. 249 DIFFERENTIAL EFFECT OF ASPIRIN ON OXIDATIVE STRESS, THROMBOXANE, NITRIC OXIDE METABOLITES AND P-SELECTIN IN TYPE 2 DIABETES MELLITUS
29. Recombinant domain V of 2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and 2-glycoprotein I complex
30. P247 ROSUVASTATIN PROMOTES ANTIOXIDANT EFFECT THROUGH NITRIC OXIDE PATHWAY AND REDUCES SERUM LEVELS OF OXIDIZED-LDL/β2GPI COMPLEXES IN PATIENTS WITH DIABETES MELLITUS
31. P120 OXIDIZED-LDL/β2-GLYCOPROTEIN I COMPLEXES AND ANTIPHOSPHOLIPID ANTIBODIES ARE ASSOCIATED WITH DISEASE SEVERITY AND RISK FOR ADVERSE OUTCOMES IN ACUTE CORONARY SYNDROME
32. Pathophysiology of β2-glycoprotein I in antiphospholipid syndrome
33. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome
34. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis
35. Oxldl/β2gpi Complex And Anti-oxldl/β2gpi In Sle: Prevalence And Correlates
36. Primary antiphospholipid syndrome: a low-grade auto-inflammatory disease?
37. Autoimmune-mediated atherothrombosis
38. Expression of anticardiolipin cofactor, human β2-glycoprotein I, by a recombinant baculovirus/insect cell system
39. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages
40. Determination of Oxidized Low-Density Lipoproteins (ox-LDL) versus ox-LDL/beta2GPI Complexes for the Assessment of Autoimmune-Mediated Atherosclerosis
41. Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation
42. Atherogenic Antiphospholipid Antibodies in Antiphospholipid Syndrome
43. Chronic Infections and Atherosclerosis
44. Subclinical Atherosclerosis in Primary Antiphospholipid Syndrome
45. Antiphospholipid Antibodies in Patients with Coronary Artery Disease: New Cardiac Risk Factors?
46. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis
47. AUTOIMMUNE MEDIATED-ATHEROSCLEROSIS: CAROTID INTIMA-MEDIA THICKNESS AND OXIDIZED LOW-DENSITY LIPOPROTEINS IN SYSTEMIC LUPUS ERYTHEMATOSUS
48. ATHEROSCLEROSIS IN PRIMARY ANTIPHOSPHOLIPID SYNDROME
49. MEASUREMENT OF OXIDIZED LOW-DENSITY LIPOPROTEINS (oxLDL) AND oxLDL/B2GPI COMPLEXES BY ELISA FOR THE ASSESSMENT OF AUTOIMMUNE-MEDIATED ATHEROSCLEROSIS
50. Atherogenic Oxidized Low-Density Lipoprotein/β2-Glycoprotein I (oxLDL/β2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.